---
title: "12 Health Care Stocks Moving In Thursday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288719427.md"
description: "In Thursday's pre-market session, several healthcare stocks showed significant volatility. Gainers included SciSparc (up 31.7%), BioLine Rx (up 14.93%), and Propanc Biopharma (up 11.31%). Conversely, major losers featured ADC Therapeutics, which plummeted 53.6%, followed by Basel Medical Group (down 26.82%) and Picard Medical (down 16.78%). The report highlights these price movements alongside respective market capitalizations for each company."
datetime: "2026-06-04T12:05:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288719427.md)
  - [en](https://longbridge.com/en/news/288719427.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288719427.md)
---

# 12 Health Care Stocks Moving In Thursday's Pre-Market Session

### Gainers

-   **SciSparc** (NASDAQ:SPRC) shares rose 31.7% to $12.46 during Thursday's pre-market session. The company's market cap stands at $5.3 million.
-   **BioLine Rx** (NASDAQ:BLRX) shares rose 14.93% to $3.77. The company's market cap stands at $14.2 million.
-   **Propanc Biopharma** (NASDAQ:PPCB) shares increased by 11.31% to $1.82. The market value of their outstanding shares is at $3.7 million.
-   **CytoSorbents** (NASDAQ:CTSO) stock moved upwards by 10.38% to $0.54. The market value of their outstanding shares is at $30.7 million.
-   **ABVC BioPharma** (NASDAQ:ABVC) stock increased by 9.37% to $1.4. The market value of their outstanding shares is at $33.2 million.
-   **Cumberland Pharma** (NASDAQ:CPIX) stock increased by 8.73% to $6.1. The market value of their outstanding shares is at $84.0 million.

### Losers

-   **ADC Therapeutics** (NYSE:ADCT) stock declined by 53.6% to $1.43 during Thursday's pre-market session. The company's market cap stands at $391.7 million.
-   **Basel Medical Group** (NASDAQ:BMGL) stock declined by 26.82% to $0.48. The company's market cap stands at $12.3 million.
-   **Picard Medical** (AMEX:PMI) stock fell 16.78% to $0.26. The company's market cap stands at $28.7 million.
-   **Genenta Science** (NASDAQ:GNTA) shares decreased by 13.73% to $1.82. The company's market cap stands at $49.4 million.
-   **Virax Biolabs Group** (NASDAQ:VRAX) stock declined by 13.37% to $0.21. The company's market cap stands at $1.7 million.
-   **SINTX Technologies** (NASDAQ:SINT) shares declined by 12.4% to $1.96. The market value of their outstanding shares is at $9.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)
- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [BLRX.US](https://longbridge.com/en/quote/BLRX.US.md)
- [ADCT.US](https://longbridge.com/en/quote/ADCT.US.md)
- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)
- [CTSO.US](https://longbridge.com/en/quote/CTSO.US.md)
- [ABVC.US](https://longbridge.com/en/quote/ABVC.US.md)
- [CPIX.US](https://longbridge.com/en/quote/CPIX.US.md)
- [GNTA.US](https://longbridge.com/en/quote/GNTA.US.md)
- [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md)
- [SINT.US](https://longbridge.com/en/quote/SINT.US.md)
- [PPCBD.US](https://longbridge.com/en/quote/PPCBD.US.md)

## Related News & Research

- [ADC Therapeutics reports positive LOTIS-5 PFS results; plans pre-sBLA meeting and Q4 2026 sBLA](https://longbridge.com/en/news/288624565.md)
- [As tech stocks slide, the healthcare sector shines. Why some experts say they like this defensive play](https://longbridge.com/en/news/289242691.md)
- [Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile](https://longbridge.com/en/news/289475996.md)
- [11:25 ETSoftware Company OnTime Announces Goal to Modernize the Home Healthcare Industry](https://longbridge.com/en/news/289211527.md)
- [Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?](https://longbridge.com/en/news/288948995.md)